Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-09 8:03 pm Purchase | 2026-06-02 | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners III, L.P. | 6,508,433 6.200% | 6,508,433 (New Position) | Filing History |
| 2026-05-15 4:36 pm Sale | 2026-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | Venrock Healthcare Capital Partners III, L.P. | 9,982,124 4.600% | -5,579,376 (-35.85%) | Filing History |
| 2026-05-15 4:35 pm Sale | 2026-03-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Venrock Healthcare Capital Partners III, L.P. | 1,726,331 2.800% | -1,500,000 (-46.49%) | Filing History |
| 2026-05-15 4:34 pm Purchase | 2026-03-31 | 13G | ERASCA INC ERAS | Venrock Healthcare Capital Partners III, L.P. | 16,382,812 5.300% | 166,596 (+1.03%) | Filing History |
| 2026-05-15 4:33 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III, L.P. | 4,319,765 4.200% | -1,356,465 (-23.90%) | Filing History |
| 2026-05-15 4:32 pm Purchase | 2026-03-31 | 13G | SURROZEN INC SRZN | Venrock Healthcare Capital Partners III, L.P. | 1,205,000 9.900% | 332,454 (+38.10%) | Filing History |
| 2026-05-15 4:31 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 1,955,105 9.900% | 1,262,146 (+182.14%) | Filing History |
| 2026-05-15 4:30 pm Purchase | 2026-03-31 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III, L.P. | 5,083,877 9.900% | 2,867,802 (+129.41%) | Filing History |
| 2026-05-15 4:29 pm Purchase | 2026-03-31 | 13G | ZURA BIO LTD ZURA | Venrock Healthcare Capital Partners III, L.P. | 9,816,384 9.900% | 3,463,031 (+54.51%) | Filing History |
| 2026-04-24 4:12 pm Purchase | 2026-04-17 | 13G | ACHIEVE LIFE SCIENCES INC ACHV | Venrock Healthcare Capital Partners III, L.P. | 5,502,064 5.200% | 5,502,064 (New Position) | Filing History |
| 2026-03-17 4:15 pm Purchase | 2026-03-10 | 13G | KORRO BIO INC KRRO | Venrock Healthcare Capital Partners III, L.P. | 1,488,685 9.900% | 1,488,685 (New Position) | Filing History |
| 2026-02-17 7:17 pm Purchase | 2026-02-09 | 13G | DAMORA THERAPEUTICS, INC DMRA | Venrock Healthcare Capital Partners III, L.P. | 3,603,595 6.000% | 3,603,595 (New Position) | Filing History |
| 2026-02-17 6:22 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Venrock Healthcare Capital Partners III, L.P. | 2,216,075 9.900% | 1,455,376 (+191.32%) | Filing History |
| 2026-02-17 6:20 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 692,959 9.900% | 139,989 (+25.32%) | Filing History |
| 2026-02-17 6:18 pm Purchase | 2025-12-31 | 13G | SAVARA INC SVRA | Venrock Healthcare Capital Partners III, L.P. | 20,881,288 9.900% | 8,200,245 (+64.67%) | Filing History |
| 2026-02-17 6:17 pm Sale | 2025-12-31 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | -750,000 (Position Closed) | Filing History |
| 2026-02-17 6:15 pm Sale | 2025-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III, L.P. | 5,676,230 5.800% | -920,655 (-13.96%) | Filing History |
| 2026-02-17 6:13 pm Sale | 2025-12-31 | 13G | OCULAR THERAPEUTIX INC OCUL | Venrock Healthcare Capital Partners III, L.P. | 6,862,972 3.200% | -6,050,448 (-46.85%) | Filing History |
| 2026-02-17 6:11 pm Purchase | 2025-12-31 | 13G | JADE BIOSCIENCES, INC. JBIO | Venrock Healthcare Capital Partners III, L.P. | 5,115,862 9.900% | 1,895,493 (+58.86%) | Filing History |
| 2026-02-17 6:09 pm Sale | 2025-12-31 | 13G | ENGENE HLDGS INC ENGN | Venrock Healthcare Capital Partners III, L.P. | 4,771,414 7.100% | -275,000 (-5.45%) | Filing History |